12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Monday. Notable gainers include Seres Therapeutics (MCRB), Renovaro (RENB), Champions Oncology (CSBR), Nanoviricides (NNVC), Semler Scientific (SMLR), and TransCode Therapeutics (RNAZ). On the losing side, Sunshine Biopharma (SBFM), Tharimmune (THAR), CNS Pharma (CNSP), Curis (CRIS), Skye Bioscience (SKYE), and Novavax (NVAX) experienced notable declines.
June 10, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Champions Oncology (CSBR) shares increased by 22.82% to $5.65, with a market cap of $76.8 million.
The notable increase in share price suggests positive news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Seres Therapeutics (MCRB) stock surged by 34.0% to $0.82, with a market cap of $124.5 million.
The significant price increase suggests positive investor sentiment or news impacting the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Nanoviricides (NNVC) stock rose 22.02% to $3.26, with a market cap of $38.4 million.
The significant price increase indicates positive investor sentiment or news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Renovaro (RENB) shares increased by 32.51% to $1.71, with a market cap of $252.1 million.
The substantial rise in share price indicates strong investor interest or favorable developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics (RNAZ) stock moved upwards by 18.63% to $1.3, with a market cap of $8.6 million.
The notable increase in share price suggests positive news or investor sentiment.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Semler Scientific (SMLR) stock moved upwards by 20.13% to $38.0, with a market cap of $268.5 million.
The substantial rise in share price suggests strong investor interest or favorable developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
CNS Pharma (CNSP) stock decreased by 27.83% to $3.65, with a market cap of $1.1 million.
The notable decrease in share price indicates negative investor sentiment or adverse news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Curis (CRIS) stock fell 19.58% to $7.11, with a market cap of $41.9 million.
The significant price drop suggests negative investor sentiment or adverse news.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Novavax (NVAX) shares decreased by 14.62% to $15.52, with a market cap of $2.2 billion.
The significant price drop suggests negative investor sentiment or adverse news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Sunshine Biopharma (SBFM) stock fell 35.6% to $0.36, with a market cap of $6.8 million.
The significant price drop indicates negative investor sentiment or adverse news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Skye Bioscience (SKYE) stock fell 15.0% to $9.3, with a market cap of $261.0 million.
The notable decrease in share price indicates negative investor sentiment or adverse news.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Tharimmune (THAR) stock fell 31.74% to $3.55, with a market cap of $2.7 million.
The substantial decline in share price suggests negative investor sentiment or unfavorable developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100